Found: 2
Select item for more details and to access through your institution.
Long-Term Immunogenicity and Safety of a Homologous Third Dose Booster Vaccination with TURKOVAC: Phase 2 Clinical Study Findings with 32-Week Post-Booster Follow-Up.
- Published in:
- Vaccines, 2024, v. 12, n. 2, p. 140, doi. 10.3390/vaccines12020140
- By:
- Publication type:
- Article
Development of an Inactivated Vaccine against SARS CoV-2.
- Published in:
- Vaccines, 2021, v. 9, n. 11, p. 1266, doi. 10.3390/vaccines9111266
- By:
- Publication type:
- Article